Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay S Cooper

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Head & Neck|January 22, 2016
ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and NeckShlomo A Koyfman, Jay S Cooper, Jonathan J Beitler, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2012
Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neckJay S Cooper, Qiang Zhang, Thomas F Pajak, et al.
The New England Journal of Medicine|May 7, 2004
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neckJay S Cooper, Thomas F Pajak, Arlene A Forastiere, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2022
Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use CriteriaMatthew C Ward, Shlomo A Koyfman, Richard L Bakst, et al.
Journal of the National Cancer Institute|April 6, 2006
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patientsFadlo R Khuri, J Jack Lee, Scott M Lippman, et al.
Head & Neck|October 24, 2020
Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteriaDanielle N Margalit, Assuntina G Sacco, Jay S Cooper, et al.
Cancer|July 16, 2016
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Vasu Divi, Jonathan Harris, Paul M Harari, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Head & Neck|January 22, 2016
ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and NeckShlomo A Koyfman, Jay S Cooper, Jonathan J Beitler, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2012
Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neckJay S Cooper, Qiang Zhang, Thomas F Pajak, et al.
The New England Journal of Medicine|May 7, 2004
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neckJay S Cooper, Thomas F Pajak, Arlene A Forastiere, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2022
Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use CriteriaMatthew C Ward, Shlomo A Koyfman, Richard L Bakst, et al.
Journal of the National Cancer Institute|April 6, 2006
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patientsFadlo R Khuri, J Jack Lee, Scott M Lippman, et al.
Head & Neck|October 24, 2020
Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteriaDanielle N Margalit, Assuntina G Sacco, Jay S Cooper, et al.
Cancer|July 16, 2016
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Vasu Divi, Jonathan Harris, Paul M Harari, et al.
Pageof 4